Building to Exit or Building to Go It Alone

Overview

Yaron Weber, Biotechnology Analyst, speaks with Jean-Francois Formela, Partner at Atlas Venture and Otello Stampacchia, Founder of Omega Funds. They discuss investing in and building companies from the ground up, particularly in light of the unprecedented pace of innovation in biotech. Science prevails when it comes to investing in early-stage biotechs, but many key strategic and financing decisions need to be made along the way, especially as relating to selling the company or going it alone.

Listen to the Podcast here.

Contact

Headshot DB

Dierk
Beyer

Partner
M&A, Cowen

+49 69 5060 675 62
Email

Tobias
Levedag

Partner
M&A, Cowen

+49 89 2000 393 70
Email

Similar Insights

Image Pharma Services Report May 22
Pharma Services Report April
Insights Cowen Valued-Based Care Health Care Business Model Transformation